BioSource International Inc., a Camarillo supplier of immunological reagents and test kits used in biomedical research, reported a $218,702 profit for its third quarter ended Sept. 30.
A year earlier, BioSource lost $4,849. Its revenue in the latest quarter was $1.45 million, up 46% from $992,534 in the comparable 1992 quarter.
For the nine months, BioSource earned $419,021, in contrast with a profit of $3,041 a year before. Its revenue rose 34%, to $4.06 million from $3.03 million.
The company's 1992 results are \o7 pro forma\f7 , meaning they are the combined results of a predecessor company, BioSource Industries Inc., and Tago Inc., which it acquired earlier this year.
BioSource also announced the appointment of its president and chief executive, James Chamberlain, to the additional post of chairman.